Skin Lesions: Types, Causes, and When to See a Doctor

You notice a new spot on your arm. It's been there for a few weeks, maybe longer. You tell yourself it's nothing, probably just a freckle you never paid attention to before. But then you catch yourself checking it again in the mirror, wondering if it's changed, if it's darker, if the edges look different than they did last week. The uncertainty sits there, unresolved, because you're not sure what you're looking at or when a spot on your skin crosses the line from normal to something that needs attention.

Key Takeaways

• Skin lesions are any areas of skin that differ from surrounding tissue.
• Primary skin lesions appear at disease onset; secondary lesions evolve from them.
• Causes range from inflammatory and infectious to systemic and neoplastic processes.
• Changes in size, shape, color, or symptoms warrant medical evaluation.
• Not all lesions are dangerous, but persistent changes require professional assessment.
• Early detection of concerning lesions significantly improves treatment outcomes.

What Skin Lesions Actually Are

A skin lesion is any area of skin that looks or feels different from the surrounding tissue. That definition is intentionally broad because skin lesions encompass an enormous range of presentations, from harmless freckles and age spots to inflammatory rashes, infections, and malignancies. The term itself is descriptive, not diagnostic. It simply means something about that patch of skin has changed in color, texture, elevation, or structure.

Dermatologists classify skin lesions into two main categories: primary and secondary. Primary skin lesions are the initial manifestations of a disease process. They appear at the onset of a condition and represent the body's first visible response to whatever is driving the change, whether that's an immune reaction, an infection, a genetic variant, or abnormal cell growth.

Common types of skin lesions in the primary category include:

• Macules are flat, discolored spots like freckles that don't rise above the skin surface.
• Papules are small raised bumps like acne that measure less than one centimeter in diameter.
• Nodules are deeper, firm lumps that extend into lower skin layers.
• Vesicles are fluid-filled blisters containing clear liquid.
• Pustules are pus-filled bumps that indicate infection or inflammation.
• Plaques are broad, elevated patches that cover larger surface areas.

Secondary skin lesions develop from primary lesions or result from external manipulation like scratching, rubbing, or infection of an existing lesion. These include scales (flaky skin), crusts (dried exudate from a wound), ulcers (deep tissue loss), scars (fibrous tissue replacing normal skin), and erosions (superficial loss of epidermis). Understanding this distinction matters because it helps clinicians trace a lesion's history and identify the underlying process driving it.

What Drives Different Types of Skin Lesions

Inflammatory mechanisms

Inflammatory lesions result from immune system activation in the skin. Conditions like eczema, psoriasis, and contact dermatitis produce lesions driven by cytokine release, immune cell infiltration, and disrupted barrier function. These lesions often present as red, scaly, or swollen patches that may itch or burn.

Infectious processes

Infectious lesions occur when bacteria, viruses, fungi, or parasites invade the skin. Bacterial infections like impetigo produce crusted, oozing lesions. Viral infections like herpes simplex create clusters of painful vesicles. Fungal infections such as ringworm cause circular, scaly patches. Each pathogen interacts with the skin's immune defenses in distinct ways, producing characteristic lesion patterns.

Neoplastic growth

Neoplastic lesions involve abnormal cell growth. Benign growths like seborrheic keratoses and skin tags are common and harmless. Malignant lesions, including basal cell carcinoma, squamous cell carcinoma, and melanoma, represent uncontrolled proliferation of skin cells. Melanoma, the most aggressive form, arises from melanocytes and can metastasize if not detected early.

Systemic disease manifestations

Systemic diseases can also manifest as skin lesions. Autoimmune conditions like lupus produce characteristic rashes. Metabolic disorders, vascular diseases, and even certain cancers can present with skin changes before other symptoms appear. The skin often serves as an early warning system for internal dysfunction.

How Skin Lesions Connect to Internal Health

The skin is not an isolated organ. It reflects the state of multiple internal systems, including immune function, hormonal balance, metabolic health, and vascular integrity. Inflammatory skin lesions often signal broader immune dysregulation. Conditions like psoriasis are associated with elevated systemic inflammation, increased cardiovascular risk, and metabolic syndrome. The same inflammatory pathways that drive skin plaques also contribute to arterial plaque formation and insulin resistance.

Hormonal shifts influence skin lesion development through several mechanisms:

• Androgens increase sebum production, contributing to acne formation and severity.
• Estrogen affects collagen synthesis and skin thickness, altering appearance during hormonal transitions.
• Cortisol impairs skin barrier function and immune response, making stress-triggered flares a real neuroimmune phenomenon.
• Thyroid dysfunction can alter skin appearance and lesion susceptibility through metabolic changes.

The gut-skin axis plays a significant role in inflammatory skin conditions. Gut microbiome composition influences systemic inflammatory tone. Increased intestinal permeability may allow bacterial endotoxins into circulation, amplifying immune activation that manifests in the skin. This connection explains why some individuals with eczema or psoriasis experience flares linked to dietary triggers or gut health disruptions. Vascular health also impacts skin lesion presentation, as conditions like venous insufficiency produce chronic ulcers and vasculitis causes purpura and necrotic lesions.

What Triggers Lesion Development and Flares

Skin barrier disruption is a common trigger. Harsh soaps, detergents, extreme temperatures, and low humidity compromise the skin's protective layer, allowing irritants and allergens to penetrate and activate immune responses. Genetic variants like filaggrin mutations, which impair barrier protein production, increase susceptibility to conditions like eczema.

Microbiome imbalance affects lesion development. The skin hosts diverse microbial communities that help defend against pathogens and modulate immune function. Disruptions from antibiotics, topical steroids, or environmental exposures can shift microbial composition, reducing protective species and allowing opportunistic pathogens to thrive. This imbalance contributes to acne, rosacea, and seborrheic dermatitis.

Environmental and lifestyle factors that trigger or worsen skin lesions include:

• UV radiation damages DNA in skin cells, leading to actinic keratoses and skin cancers.
• High glycemic load diets increase insulin and IGF-1 signaling, stimulating sebum production and keratinocyte proliferation.
• Omega-6 to omega-3 fatty acid imbalance promotes prostaglandin-mediated inflammation in conditions like eczema.
• Medications like lithium, beta-blockers, and NSAIDs can exacerbate psoriasis or cause photosensitivity reactions.

Why the Same Lesion Looks Different in Different People

Genetics play a substantial role in lesion presentation and susceptibility. Filaggrin gene variants increase eczema risk and severity. HLA gene variants influence psoriasis susceptibility and subtype. MC1R variants affect UV sensitivity and melanoma risk. Genetic determinants of sebum production and androgen receptor sensitivity shape acne presentation.

Skin microbiome composition varies widely between individuals. Not all strains of Cutibacterium acnes are equally inflammatory. Some people harbor more aggressive strains that drive severe acne, while others with similar sebum production experience minimal breakouts. Prior antibiotic use shapes microbiome resilience and diversity, affecting how the skin responds to future challenges.

Individual variation in immune response and skin characteristics includes:

• Th1-dominant immune responses produce different lesion patterns than Th2-dominant responses.
• Mast cell reactivity varies, affecting IgE-mediated versus non-IgE-mediated response severity.
• Baseline inflammatory tone differs between individuals, influencing symptom presentation and treatment response.
• Melanin content affects both lesion appearance and risk of post-inflammatory hyperpigmentation.

When Skin Lesions Signal Something Systemic

Persistent or treatment-resistant skin lesions warrant deeper investigation. Acne that doesn't respond to standard treatments may signal underlying insulin resistance, hyperandrogenism, or polycystic ovary syndrome (PCOS). Checking fasting insulin, testosterone, DHEA-S, and SHBG can reveal metabolic or hormonal drivers.

Psoriasis is associated with elevated cardiovascular risk due to shared inflammatory pathways. Individuals with moderate to severe psoriasis should have hsCRP, lipid panels, and metabolic markers monitored. Up to 30% of psoriasis patients develop psoriatic arthritis, making joint symptoms an important consideration.

Eczema, particularly when severe or persistent, may be linked to food allergies, asthma, or allergic rhinitis (a progression known as the atopic march). Total IgE, specific IgE panels, and eosinophil counts can help identify allergic drivers. Chronic eczema also disrupts sleep and mental health, making these secondary impacts worth addressing.

Other systemic connections include:

• Rosacea has been associated with Helicobacter pylori infection and small intestinal bacterial overgrowth (SIBO).
• Seborrheic dermatitis correlates with Parkinson's disease, HIV, and nutritional deficiencies (particularly B vitamins and zinc).
• Persistent lesions may indicate underlying autoimmune conditions, metabolic disorders, or immune dysfunction.

What Testing Reveals When Lesions Persist

When topical treatments alone aren't resolving a skin condition, looking at systemic biomarkers adds interpretive depth. For acne with suspected hormonal drivers, measuring free and total testosterone, DHEA-S, SHBG, LH/FSH ratio, fasting insulin, and IGF-1 can identify underlying endocrine imbalances. For gut-related drivers, a gut microbiome panel or markers like zonulin (intestinal permeability) and hsCRP provide insight into systemic inflammation.

Condition-specific testing approaches include:

• For psoriasis with systemic concerns: track hsCRP, ESR, lipid panels, fasting glucose, HbA1c, and uric acid to assess cardiovascular and metabolic risk.
• For eczema with suspected allergic drivers: check total IgE, specific IgE panels, eosinophil count, ferritin, Vitamin D, and thyroid function.
• For rosacea with gastrointestinal symptoms: consider H. pylori antibody testing, SIBO breath test, Vitamin D, and B12 levels.
• For joint symptoms with psoriasis: anti-CCP antibodies may indicate psoriatic arthritis development.

A single skin flare is information. A pattern of flares with systemic correlates is a signal. Tracking relevant biomarkers over time, not just reacting to individual flares, is more likely to identify the underlying driver and guide more effective interventions.

Turning Skin Symptoms Into Systemic Investigation

If your skin lesions keep coming back despite doing everything right topically, Superpower's 100+ biomarker panel can show you what's happening beneath the surface. Hormones, metabolic markers, inflammatory signals, nutrient levels, and immune function all influence how your skin behaves. Persistent acne, eczema, psoriasis, or unexplained rashes aren't just skin problems. They're often signals of internal imbalances that standard skincare can't address. Superpower's testing helps you read those signals at a systemic level, so your next step is based on data, not guesswork.